These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 10421663

  • 1. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa.
    Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE.
    Hepatology; 1999 Aug; 30(2):526-30. PubMed ID: 10421663
    [Abstract] [Full Text] [Related]

  • 2. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus.
    Miyazoe S, Hamasaki K, Nakata K, Kajiya Y, Kitajima K, Nakao K, Daikoku M, Yatsuhashi H, Koga M, Yano M, Eguchi K.
    Am J Gastroenterol; 2002 Aug; 97(8):2086-92. PubMed ID: 12190181
    [Abstract] [Full Text] [Related]

  • 3. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
    Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, Park CS, Lee JE, Hahm KB, Kim JH.
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
    Wietzke-Braun P, Maouzi AB, Mänhardt LB, Bickeböller H, Ramadori G, Mihm S.
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):991-7. PubMed ID: 16894313
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.
    Naito M, Matsui A, Inao M, Nagoshi S, Nagano M, Ito N, Egashira T, Hashimoto M, Mishiro S, Mochida S, Fujiwara K.
    J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370
    [Abstract] [Full Text] [Related]

  • 8. The effects of interleukin 10 and interferon gamma cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer.
    Wu JM, Bensen-Kennedy D, Miura Y, Thoburn CJ, Armstrong D, Vogelsang GB, Hess AD.
    Biol Blood Marrow Transplant; 2005 Jun; 11(6):455-64. PubMed ID: 15931634
    [Abstract] [Full Text] [Related]

  • 9. Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection.
    Barrett S, Collins M, Kenny C, Ryan E, Keane CO, Crowe J.
    J Med Virol; 2003 Oct; 71(2):212-8. PubMed ID: 12938195
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. IL-10 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin.
    Schippers EF, van 't Veer C, van Voorden S, Martina CA, Huizinga TW, le Cessie S, van Dissel JT.
    Cytokine; 2005 Mar 07; 29(5):215-28. PubMed ID: 15760678
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-10 production genotype protects against acute persistent rejection after lung transplantation.
    Zheng HX, Burckart GJ, McCurry K, Webber S, Ristich J, Iacono A, Dauber J, McDade K, Grgurich W, Zaldonis D, Pillage G, Griffith BP, Zeevi A.
    J Heart Lung Transplant; 2004 May 07; 23(5):541-6. PubMed ID: 15135368
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M, Chrobot A, Szaflarska-Szczepanik A.
    Med Sci Monit; 2000 May 07; 6(5):964-70. PubMed ID: 11208439
    [Abstract] [Full Text] [Related]

  • 16. Possible involvement of cytokine gene polymorphisms in fulminant hepatitis.
    Takakura M, Tokushige K, Matsushita N, Hashimoto E, Shiratori K.
    J Gastroenterol Hepatol; 2007 Aug 07; 22(8):1271-7. PubMed ID: 17559370
    [Abstract] [Full Text] [Related]

  • 17. Polymorphisms in the interferon-gamma gene at position +874 in patients with chronic hepatitis C treated with high-dose interferon-alpha and ribavirin.
    Dai CY, Chuang WL, Chang WY, Chen SC, Lee LP, Hsieh MY, Hou NJ, Lin ZY, Hsieh MY, Wang LY, Yu ML.
    Antiviral Res; 2005 Aug 07; 67(2):93-7. PubMed ID: 16051377
    [Abstract] [Full Text] [Related]

  • 18. Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients.
    Wada M, Marusawa H, Yamada R, Nasu A, Osaki Y, Kudo M, Nabeshima M, Fukuda Y, Chiba T, Matsuda F.
    J Viral Hepat; 2009 Jun 07; 16(6):388-96. PubMed ID: 19200137
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interleukin-10 promoter polymorphisms in myasthenia gravis.
    Alseth EH, Nakkestad HL, Aarseth J, Gilhus NE, Skeie GO.
    J Neuroimmunol; 2009 May 29; 210(1-2):63-6. PubMed ID: 19299022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.